Milestone Executives to Present at TD Cowen Healthcare Conference
Event summary
- Milestone Pharmaceuticals executives Amit Hasija (CFO) and Lorenz Muller (CCO) will present at the TD Cowen 46th Annual Health Care Conference.
- The conference takes place March 2-4, 2026, in Boston.
- A webcast of the presentation will be available on March 3rd at 9:10 AM EST.
- Investors interested in meeting with Milestone’s team should contact their TD Cowen representative.
The big picture
Milestone's participation in a major healthcare conference underscores its ongoing efforts to raise investor awareness and potentially secure additional funding. The company's focus on cardiovascular medicines, particularly etripamil’s expansion beyond PSVT, positions it within a competitive but growing market segment. The conference provides a platform to articulate the company’s strategy and address investor questions regarding its commercialization efforts and pipeline development.
What we're watching
- Investor Relations
- The presentation and availability of a webcast suggest Milestone is actively engaging with investors, potentially to address concerns or highlight progress on their AFib-RVR development program.
- Commercial Execution
- The presence of the Chief Commercial Officer indicates a focus on CARDAMYST’s market penetration and future growth, which will be critical for Milestone’s financial performance.
- Pipeline Progress
- The conference presentation will likely provide updates on the progress of etripamil’s development for AFib-RVR, a significantly larger market opportunity than its current PSVT indication.
Related topics